Trial NCT02906696

View at ClinicalTrials.gov 
Org. Study IDs: 2016-0081
Secondary IDs: 2016-0081 NCI-2016-01954 P30CA016672

Last trial update was posted on 2020-05-11

MeSH Interventions

Bosutinib

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Chronic-Phase

Other Conditions

Blasts Under 15 Percent of Bone Marrow Nucleated Cells Blasts Under 15 Percent of Peripheral Blood White Cells Blasts Under 30 Percent of Bone Marrow Nucleated Cells Blasts Under 30 Percent of Peripheral Blood White Cells Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Stopping Reasons

Terminated per PI's request due to competing priorities.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID